Monitor for follow-up filings or commentary around corporate performance; repeated C-suite selling could signal weakening confidence, especially if not part of a pre-arranged 10b5-1 plan. Check upcoming earnings date and recent stock performance for context.
Price Chart
Executive Summary
Multiple NovoCure executives, including CEO Leonard Frank X and Chief Medical Officer Uri Weinberg, conducted open-market share sales over a 7-day period, totaling approximately $434,000 in gross proceeds. These sales were accompanied by non-cash grant and tax withholding events involving former and current executives. The selling activity represents modest insider divestment by senior leaders.
Key Financial Metrics
Key Facts
- CEO Leonard Frank X sold 16,966 shares for $230,584.81 in open-market transactions.
- Chief Medical and Innovation Officer Uri Weinberg sold 10,733 shares for $146,863.44.
- COO Mukund and CHRO Puri also sold shares, totaling $26,752.35 and $19,689.54 respectively.
- Total open-market sales by insiders: 32,851 shares for ~$434,000.
- Tax withholding events (non-cash) for former CEO Cordova totaled ~$191,633.
- All share grants (totaling over 73,000 shares) were non-cash awards with $0 transaction value.
- Total insider selling represents ~0.029% of $1.5B market cap — modest but notable given concentration among C-suite.
Financial Impact
$434,000 in open-market insider selling over 7 days
Risk Factors
- Perception of insider pessimism given participation by CEO and top medical officer.
- Lack of offsetting open-market purchases increases bearish interpretation.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (13 trades, 7d window) | cluster-NVCR-1772574379465 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $15.63 $16.38 | ▲ +4.80% | ▲ +5.13% | $14.94 (−4.41%) |
Sep 1, 2026 4w ago | 8-K | $17.38 $15.63 | ▼ −10.07% | ▼ −10.15% | $14.94 (−14.04%) |
Jul 23, 2026 10w ago | 8-K | $19.99 $15.23 | ▼ −23.81% | ▼ −24.29% | $14.94 (−25.26%) |
Jun 30, 2026 13w ago | 8-K | $15.15 $17.32 | ▲ +14.32% | ▲ +13.72% | $14.94 (−1.39%) |
Jun 18, 2026 15w ago | 8-K | $14.28 $15.05 | ▼ −5.39% | ▼ −7.06% | $14.94 (−4.62%) |
Jun 5, 2026 17w ago | 8-K | $16.85 $17.60 | ▲ +4.45% | ▲ +2.34% | $14.94 (−11.34%) |
Jun 3, 2026 17w ago | Insider Cluster | $17.99 $17.71 | ▼ −1.56% | ▲ +1.00% | $14.94 (−16.95%) |
Jun 3, 2026 17w ago | Insider Cluster | $17.99 $17.71 | ▼ −1.56% | ▲ +1.00% | $14.94 (−16.95%) |
Apr 20, 2026 23w ago | DEFA14A | $12.23 $12.12 | ▼ −0.90% | ▼ −1.98% | $14.94 (+22.16%) |
Feb 27, 2026 31w ago | Insider Cluster | $13.67 $13.04 | ▼ −4.61% | ▼ −2.63% | $14.94 (+9.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access